CLINICAL_TRIALS
trial_result
· 2021-09-16
Clinical Trial Update: Cabozantinib for Adults With Advanced Soft Tissue Sarcoma [Phase 2]
Summary
Phase 2 clinical trial update evaluating cabozantinib in adults with refractory soft tissue sarcomas has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Refractory Soft Tissue Sarcomas | Phase 2 | Status: COMPLETED | Results posted: 2021-09-16